About this trial

Retrospective prospective Multicentric clinical follow up of patients with severe tricuspid regurgitation after being treated with the TricValve® Transcatheter Bicaval Valves System.

Eligibility criteria

Qualifiers

Successful treatment with TricValve Transcatheter Bicaval Valves System

Patient/patient's authorized legal guardian gives his consent to participate in the study and signed the corresponding inform consent

Disqualifiers

no exclusion criterion

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

No trial groups listed

Locations

28
Austria
Universitätsklinikum St. Pölten3100, Sankt PöltenLower Austria, Austria
Medizinische Universität Wien, Department of Cardiac Surgery1090, Vienna Austria
Medizinische Universität Wien, Universitätsklinik für Innere Medizin II1090, Vienna Austria
Belgium
Department of Cardiology, Algemeen Stedelijk Ziekenhuis (ASZ)9300, Aalst Belgium

Sponsors and collaborators

P+F Products + Features GmbH

Lead sponsor